Other analysts also recently issued research reports about the stock. Bankhaus Lampe set a €135.00 ($156.98) price target on shares of Hannover Re and gave the stock a neutral rating in a report on Wednesday, November 6th. Goldman Sachs Group set a €130.00 ($151.16) price objective on shares of Hannover Re and gave the company a sell rating in a research note on Wednesday, November 13th. Deutsche Bank set a €145.00 ($168.60) price objective on shares of Hannover Re and gave the company a neutral rating in a research note on Friday, November 22nd. JPMorgan Chase & Co. set a €133.00 ($154.65) price objective on shares of Hannover Re and gave the company a sell rating in a research report on Tuesday. Finally, Jefferies Financial Group set a €140.00 ($162.79) target price on Hannover Re and gave the stock a neutral rating in a research note on Wednesday, August 14th. Six equities research analysts have rated the stock with a sell rating and nine have given a hold rating to the company’s stock. The company presently has an average rating of Hold and a consensus price target of €135.96 ($158.09).
HNR1 opened at €168.40 ($195.81) on Wednesday. Hannover Re has a 52-week low of €94.75 ($110.17) and a 52-week high of €116.37 ($135.31). The business’s fifty day moving average is €163.78 and its 200-day moving average is €149.45.
Hannover Re Company Profile
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Featured Story: Technical Analysis
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.